Business
DECN Assesses Its Recent Landmark Legal Victories Over Diabetes Division Of Johnson & Johnson
DECN Assesses Its Recent Landmark Legal Victories Over Diabetes Division Of Johnson & Johnson.
About this update from Decision Diagnostics Corp
[{"type":"text","content":"\n\n\n\nDECN Assesses Its Recent Landmark Legal Victories Over Diabetes Division Of Johnson & Johnson\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nDECN Assesses Its Recent Landmark Legal Victories Over Diabetes Division Of Johnson & Johnson\nPR Newswire\nLOS ANGELES, Jan. 28, 2016\n\n\n\nLOS ANGELES, Jan. 28, 2016 /PRNewswire/ -- Decision Diagnostics Corp. (OTC PINK: DECN), the manufacturer, quality plan administrator and the exclusive worldwide sales, service and regulatory processes agent for the popular GenStrip™ 50, the FDA cleared Green Glucose Test Strip, specifically designed to work with the market leading Johnson & Johnson's (\"J&J\") LifeScan OneTouch Ultra family of glucose testing meters, today publishes the first of three detailed analyses concerning: 1) the legal history and current situation of the litigation with the division of J&J, 2) the most recent rulings and upcoming events and their implications to the company, and finally 3) the sea change in the business landscape brought about by the recent ruling. To summarize the current topics:\n\n\nJ&J has exhausted all fertile avenues to continue their questionable behavior toward DECN's customers and the customers of DECN's customers, based on strong suggestion and vague legal opinion concerning J&J's centerpiece '105 patent. J&J's use of this patent to intimidate DECN's customers during the litigation process will be part of DECN's overall forward legal strategy that will shortly be pursued. \nDECN is now in an unequivocal position to pursue damages originally anticipated when the district court judge ordered a $12.7 million bond be lodged. \nWhile J&J still has a single older patent it may continue to pursue, DECN believes J&J's position is even weaker with this patent because it is believed that this older patent (known as the '862 patent) is not practiced by J&J or DECN and more importantly in our opinion this patent discusses technical features that were impossible to achieve when the patent was granted, and even today many years late...